Daniel R. Gomez

Daniel R. Gomez

Auto-generated profile, based on publicly available information

Daniel R. Gomez

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2016 in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
Verified
Journal Article
Closed access
LZLina Zhao
Lina Zhao
Shouhao ZhouShouhao Zhou
Shouhao Zhou
PBPeter Balter
Peter Balter
CSChan Shen
Chan Shen
DGDaniel R. Gomez
Daniel R. Gomez
JCJoe Y. Chang
Joe Y. Chang

1 March 2013 in Radiotherapy and Oncology
Verified
Journal Article
Open access
JEJaden D. Evans
Jaden D. Evans
DGDaniel R. Gomez
Daniel R. Gomez
AAArya Amini
Arya Amini
NRNeal Rebueno
Neal Rebueno
PAPamela K. Allen
Pamela K. Allen
JWJames W. Welsh
James W. Welsh
Improved radiation delivery and planning has allowed, in some instances, for the retreatment of thoracic tumors. We investigated the dose limits of the aorta wherein grade 5 aortic toxicity was observed after reirradiation of lung tumors. In a retrospective analysis, 35 patients were identified, between 1993 and 2008, who received two rounds of external beam irradiation that included the aorta in the radiation fields of both the initial and retreatment plans. We determined the maximum cumulative dose to 1 cm(3) of the aorta (the composite dose) for each patient, normalized these doses to 1.8 Gy/fraction, and corrected them for long-term tissue recovery between treatments (NIDR). The median time interval between treatments was 30 months (range, 1-185 months). The median follow-up of patients alive at analysis was 42 months (range, 14-70 months). Two of the 35 patients (6%) were identified as having grade 5 aortic toxicities. There was a 25% rate of grade 5 aortic toxicity for patients receiving composite doses ≥120.0 Gy (vs. 0% for patients receiving <120.0 Gy) (P=0.047). Grade 5 aortic toxicities were observed with composite doses ≥120.0 Gy (NIDR ≥90.0 Gy) to 1cm(3) of the aorta.

28 November 2019 in Radiotherapy and Oncology
Verified
Journal Article
Closed access
NSNarek Shaverdian
Narek Shaverdian
MOMichael D. Offin
Michael D. Offin
ARAndreas Rimner
Andreas Rimner
ASAnnemarie F. Shepherd
Annemarie F. Shepherd
AWAbraham J. Wu
Abraham J. Wu
DGDaniel R. Gomez
Daniel R. Gomez

6 May 2013 in Journal of Applied Clinical Medical Physics
Verified
Journal Article
Open access
PDF file
LCLaurence Edward Court
Laurence Edward Court
STSusan L. Tucker
Susan L. Tucker
DGDaniel Gomez
Daniel Gomez
ZLZhongxing Liao
Zhongxing Liao
JZJoy Zhang
Joy Zhang
MMMary K. Martel
Mary K. Martel
The purpose of the study was to examine whether CT imaging can be used to quantify radiation-induced injury to the esophagus. Weekly CT images for 14 patients receiving proton therapy for thoracic tumors were retrospectively reviewed. The images were registered with the original treatment planning CT image using deformable registration techniques, and the esophageal contours from the treatment plan were automatically mapped to the weekly images. The relative change in the size of the esophagus was calculated for each CT slice as the ratio of the cross-sectional area of the esophagus (minus air) in the weekly CT image to the same area in the planning CT image. The maximum relative change in cross-sectional area for each CT image was calculated and examined for correlation with the clinical toxicity score for all the patients. The average maximum relative expansion of the esophagus at the end of treatment was 1.41?0.26,1.68?0.36 , and 2.10?0.18 for patients with grade 0, 2, and 3 esophagitis, respectively. An unpaired t-test, with the level of significance corrected with a Bonferroni correction, showed that the difference between grade 3 and 0 was significant, but the differences between grade 0 and 2, and 2 and 3 were not. The timing of changes in esophageal expansion closely matched that of clinically noted changes in patient symptoms. Expansion of the esophagus on CT images has potential as an objective measure of toxicity. The ability to quantify objectively the spatial distribution of radiation-induced injury will be a useful tool in understanding the impact of partial esophageal sparing on the probability of esophagitis. PACS number: 87.55.dh

1 November 2014 in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
Verified
Journal Article
Open access
PDF file
QNQ. Nguyen
Q. Nguyen
RKRitsuko U. Komaki
Ritsuko U. Komaki
ZLZhongxing Liao
Zhongxing Liao
NLN. Ly
N. Ly
LLL. Levy
L. Levy
JCJ.D. Cox
J.D. Cox
To report 5 year survival outcomes and toxicity in stage II and stage III non-small cell lung cancer (NSCLC) patients treated with definitive concurrent chemotherapy and proton beam radiation therapy.